Cristiana Pascutto

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Journal: Leukemia

Published: November 17, 2016

Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis.

Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis.

Journal: Transplantation

Published: May 26, 2016

Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.

Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.

Journal: Hematological oncology

Published: January 14, 2016

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.

Journal: Blood

Published: July 03, 2014

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

Journal: Blood

Published: June 28, 2014

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Journal: Leukemia

Published: March 19, 2014

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.

Journal: Blood

Published: February 22, 2014

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.

Journal: Blood

Published: February 21, 2014

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.

Journal: Blood

Published: January 21, 2014

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

Journal: Blood

Published: December 25, 2013

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Journal: The New England journal of medicine

Published: December 12, 2013

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

Journal: Blood

Published: September 28, 2013

Showing 1-12 of 30

Last Updated: 09/26/2026